Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.19.3.a.u2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Cash Flows From Operating Activities:    
Net loss $ (11,746) $ (7,527)
Stock-based compensation expense 2,059 1,694
Depreciation and amortization expense 9 42
Fair value of warrants issued for services 73 6
Accretion of debt discount and issuance costs 0 1,581
Impairment of long-lived assets 0 33
Loss on sale of equipment 0 23
Gain on lease termination 0 (168)
Gain from change in fair value of embedded derivatives 0 (74)
Changes in operating assets and liabilities:    
Decrease in prepaid expenses and other assets 423 249
Increase in accounts payable 690 337
Increase (decrease) in accrued liabilities (28) 721
Decrease in license fees payable to Xoma (5,891) 0
Net cash used in operating activities (14,411) (3,083)
Cash Flows Provided by Investing Activities:    
Proceeds from sale of equipment 0 195
Cash Flows From Financing Activities:    
Payments for advisory fees and other offering costs (1,500) 0
Proceeds from Series AA financing exclusivity payment 0 1,500
Net cash provided by financing activities 22,550 1,500
Net increase (decrease) in cash, cash equivalents and restricted cash 8,139 (1,388)
Cash, cash equivalents and restricted cash, beginning of period 11,573 1,646
Cash, cash equivalents and restricted cash, end of period 19,712 258
Cash, Cash equivalents and Restricted cash:    
Cash and cash equivalents, end of period 18,182 258
Restricted cash, end of period 1,530 0
Cash, cash equivalents and restricted cash, end of period 19,712 258
Supplementary Cash Flow Information:    
Cash paid for interest 0 0
Cash paid for income taxes 0 0
Related Parties [Member]    
Cash Flows From Financing Activities:    
Proceeds from issuance of common stock 20,000 0
Other Investors [Member]    
Cash Flows From Financing Activities:    
Proceeds from issuance of common stock $ 4,050 $ 0